Con­fi­dent he’ll be ex­on­er­at­ed on fraud charges, Mar­tin Shkre­li is work­ing on an­oth­er at­tempt to “shock and awe”

Mar­tin Shkre­li speaks dur­ing an in­ter­view with Bloomberg on Fri­day, Dec. 23, 2016. Shkre­li said the na­tion­al out­rage over drug pric­ing was blown out of pro­por­tion and height­ened by the U.S. pres­i­den­tial elec­tion, al­though he con­ced­ed he could have pre­dict­ed the blow­back bet­ter. Vic­tor J. Blue/Bloomberg via Get­ty Im­ages

Mar­tin Shkre­li has a date with pro­s­ec­tors at the fed­er­al cour­t­house in two months, but the no­to­ri­ous biotech en­tre­pre­neur still has time to talk with re­porters. And it turns out he’s work­ing on yet an­oth­er biotech start­up as his lawyers pre­pare to de­fend him on crim­i­nal fraud charges.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER